Metastasis: stopping the spread
For decades, cancer researchers focused on shrinking primary tumours. But now some pioneers are trying to zero in on what’s the most common cause of malignancy and death in those who have the disease: metastasis. Our understanding of the process is still limited, but the technological toolbox is growing. Novel approaches to the problem from different research teams are leading to groundbreaking strategies set to take the fight against cancer to a whole new level.
In this issue:
- Biosimilars: Innovators are suffering under the EP’s taste for the SPC waiver
- Fragrances: Cosmetics giants seeking to ride the sustainability wave
- Device + Drug: Novel combination products are therapeutic game-changers
- Bioprocessing: Synthetic biologists demand global manufacturing standards